Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

NCT03167411 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: Bexagliflozin
DRUG: Exenatide Injection

Sponsor

Theracos